Indacaterol Acetate/Mometasone Furoate Provides Sustained Improvements in Lung Function Compared With Salmeterol Xinafoate/Fluticasone Propionate in Patients With Moderate-To-Very-Severe COPD: Results From a Phase II Randomized, Double-Blind 12-Week Study

International Journal of COPD - New Zealand

doi 10.2147/copd.s179293